Aug 6, 2026 07:00AM
May 12, 2026 04:18PM
May 7, 2026 07:00AM
May 6, 2026 08:01AM
May 6, 2026 08:01AM
Apr 14, 2026 10:37AM
Apr 14, 2026 07:00AM FDA approves FILSPARI for rare kidney disease FSGS
Apr 14, 2026 07:00AM
Feb 26, 2026 07:00AM
Nov 10, 2025 04:10PM
Nov 7, 2025 08:01AM
Nov 6, 2025 07:00AM
Oct 16, 2025 07:00AM
Oct 9, 2025 07:01AM SQ Innovation receives FDA approval for at-home heart failure treatment
Oct 9, 2025 07:00AM
Aug 29, 2025 06:53AM
Aug 7, 2025 07:00AM
Aug 5, 2025 07:02AM
Jul 31, 2025 04:01PM
Jul 31, 2025 04:01PM
Jul 10, 2025 08:02AM Ligand earns $5 million milestone as partner launches molluscum drug
Jul 10, 2025 08:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jul 2, 2025 07:00AM
May 8, 2025 07:00AM
Apr 17, 2025 06:00AM
Feb 27, 2025 07:00AM Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 25, 2025 07:27AM
Feb 25, 2025 07:00AM
Dec 10, 2024 09:15AM
Dec 10, 2024 09:00AM
Nov 7, 2024 07:00AM
Oct 17, 2024 07:30AM
Sep 6, 2024 09:20AM Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
Aug 6, 2024 04:01PM
Jul 24, 2024 06:33AM
Jul 24, 2024 06:30AM
Jun 28, 2024 06:40AM
Jun 27, 2024 08:03AM
Jun 27, 2024 08:00AM
Jun 18, 2024 08:00AM Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
May 7, 2024 04:00PM
May 7, 2024 07:30AM
May 7, 2024 07:30AM
Apr 8, 2024 08:16AM
Apr 8, 2024 08:15AM
Apr 3, 2024 09:01AM
Apr 3, 2024 09:00AM Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Feb 27, 2024 07:00AM

328,604 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All